Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Susan Regan, Ph.D.

Co-Author

This page shows the publications co-authored by Susan Regan and Ingrid Bassett.
Connection Strength

2.215
  1. Factors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa. PLoS One. 2013; 8(4):e62362.
    View in: PubMed
    Score: 0.551
  2. Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa. Pediatr Infect Dis J. 2017 03; 36(3):311-313.
    View in: PubMed
    Score: 0.180
  3. Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort. J Int Assoc Provid AIDS Care. 2017 Jan/Feb; 16(1):98-104.
    View in: PubMed
    Score: 0.175
  4. Finding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South Africa. AIDS Behav. 2015 Oct; 19(10):1888-95.
    View in: PubMed
    Score: 0.163
  5. High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria. BMC Infect Dis. 2015 Sep 30; 15:397.
    View in: PubMed
    Score: 0.163
  6. HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years. Int J STD AIDS. 2015 Sep; 26(10):704-9.
    View in: PubMed
    Score: 0.152
  7. The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa. Open Forum Infect Dis. 2014 Sep; 1(2):ofu058.
    View in: PubMed
    Score: 0.151
  8. Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa. HIV Med. 2014 Jul; 15(6):367-72.
    View in: PubMed
    Score: 0.143
  9. Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav. 2012 Nov; 16(8):2226-35.
    View in: PubMed
    Score: 0.133
  10. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS. 2010 Jan; 24 Suppl 1:S37-44.
    View in: PubMed
    Score: 0.110
  11. Beyond T Staging in the "Treat-All" Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa. J Acquir Immune Defic Syndr. 2021 08 15; 87(5):1119-1127.
    View in: PubMed
    Score: 0.061
  12. The role of dermatology in Kaposi sarcoma diagnosis across 3 regions in sub-Saharan Africa. J Am Acad Dermatol. 2020 Aug 04.
    View in: PubMed
    Score: 0.057
  13. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya. BMC Cancer. 2020 Jan 29; 20(1):71.
    View in: PubMed
    Score: 0.055
  14. High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian Cohort. . 2018 07 01; 78(3):322-328.
    View in: PubMed
    Score: 0.049
  15. Age Matters: Increased Risk of Inconsistent HIV Care and Viremia Among Adolescents and Young Adults on Antiretroviral Therapy in Nigeria. J Adolesc Health. 2016 09; 59(3):298-304.
    View in: PubMed
    Score: 0.043
  16. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010 Mar 04; 5(3):e9538.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.